menu
    • menu

    Company profile for Zenara Pharma

    Biophore Mix GIF-PSE
    News
    Zenara’s Generics Tafamidis Receives Tentative Approval in Us

    27 Oct 2025

    // FDA

    US FDA Approves Zenara Pharma's Generic Sertraline Hydrochloride

    05 Aug 2025

    // EXPRESSPHARMA

    Zenara Pharma Gets FDA Nod for First Generic Sertraline

    01 Aug 2025

    // PR NEWSWIRE

    DATA COMPILATION
    #PharmaFlow

    Biophore

    Contact Supplier

    Website

    BIO Partnering at JPM

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content

    radio-compass-blog/antibiotic-market-to-reach-us-74-07-billion-by-2033-fda-approves-gsk-s-blujepa-for-uncomplicated-utis

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Related CompaniesRelated Companies

    About

    Our state-of-the-art manufacturing facility at Cherlapally, Hyderabad is designed, equipped and maintained as per latest cGMP norms. The company’s manufacturing facility is fully equipped to manufacture both Solid Orals (Tablets, Capsules) and Oral liquids in various therapeutic categories. Zenara has in-house capability to ensure regulatory compliance in all the markets we operate in. We are constantly strengthening our global supply chain with customers in key markets including United States of America, Europe, Australia, New Zealand, Canada, Far East Asia, GCC (Gulf Cooperation Council), Brazil among others.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zenara Pharmaindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Plot No.83/B, 84 & 87 to 96, Phase - III, IDA Cherlapally, Hyderabad - 500 051
    Telephone
    Telephone
    +91 4027260848
    Client Email
    Email
    info@biophore.com
    Client Website
    Website
    https://www.zenarapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/zenara-pharma-pvt-ltd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/home
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Zenara’s Generics Tafamidis Receives Tentative Approval in Us
    Zenara’s Generics Tafamidis Receives Tentative Approval in Us

    27 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218205

    FDA
    27 Oct 2025
    Share Share
    US FDA Approves Zenara Pharma's Generic Sertraline Hydrochloride
    US FDA Approves Zenara Pharma's Generic Sertraline Hydrochloride

    05 Aug 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/zenara-pharma-receives-us-fda-approval-for-generic-sertraline-hydrochloride-capsules/

    EXPRESSPHARMA
    05 Aug 2025
    Share Share
    Zenara Pharma Gets FDA Nod for First Generic Sertraline
    Zenara Pharma Gets FDA Nod for First Generic Sertraline

    01 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/zenara-pharma-receives-us-fda-approval--for-first-generic-of-sertraline-hydrochloride-capsules-with-180-day-cgt-exclusivity-302519297.html

    PR NEWSWIRE
    01 Aug 2025
    Share Share
    Zenara`s Generics Sapropterin Receives Approval in US
    Zenara`s Generics Sapropterin Receives Approval in US

    11 Jun 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218797

    FDA
    11 Jun 2025
    Share Share
    Zenara`s Generics Nitazoxanide Receives Approval in US
    Zenara`s Generics Nitazoxanide Receives Approval in US

    03 Feb 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214844

    FDA
    03 Feb 2025
    Share Share
    Zenara Pharma`s Generics Tafamidis Receives Tentative Approval in US
    Zenara Pharma`s Generics Tafamidis Receives Tentative Approval in US

    21 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218205

    FDA
    21 Aug 2024
    Share Share

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search